Opus Genetics, Inc.
IRD
$1.15
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -34.05% | 1.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -34.05% | 1.58% | |||
| Cost of Revenue | -24.46% | 1.39% | |||
| Gross Profit | 12.54% | -1.15% | |||
| SG&A Expenses | -9.08% | -11.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.56% | -0.22% | |||
| Operating Income | 10.30% | 1.00% | |||
| Income Before Tax | 9.45% | 76.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.45% | 76.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.45% | 76.68% | |||
| EBIT | 10.30% | 1.00% | |||
| EBITDA | 10.33% | 1.10% | |||
| EPS Basic | 51.57% | 79.11% | |||
| Normalized Basic EPS | 51.56% | -2.86% | |||
| EPS Diluted | 51.57% | 79.11% | |||
| Normalized Diluted EPS | 51.56% | -2.86% | |||
| Average Basic Shares Outstanding | 87.03% | 11.61% | |||
| Average Diluted Shares Outstanding | 87.03% | 11.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||